Latest Breaking News On - Recursos ltda - Page 7 : comparemela.com

Short Interest in Cosan S A (NYSE:CSAN) Grows By 42 3%

Cosan S.A. (NYSE:CSAN – Get Free Report) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 920,400 shares, a growth of 42.3% from the April 30th total of 646,600 shares. Based on an average daily trading volume, of 381,700 shares, […]

Recursos ltdaO shaughnessy asset managementCosan company profileMirae asset global investments coShaughnessy asset managementTower research capitalGet free reportResearch capitalMirae asset global investmentsStock downCosan daily

Companhia Paranaense de Energia – COPEL (NYSE:ELP) Shares Down 2 4%

Companhia Paranaense de Energia – COPEL (NYSE:ELP) Shares Down 2 4%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Companhia paranaense de energiaRecursos ltdaCapital wealth planningDorsey wright associatesOptiver holdingGet free reportParanaense de energiaCapital management gestora de recursosPower generationPower distributionPower sale

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Director Buys $49,995 96 in Stock

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Director Buys $49,995 96 in Stock
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Alang levinRecursos ltdaBiocryst pharmaceuticals incNews ratings for biocryst pharmaceuticals dailyTower research capitalBiocryst pharmaceuticals trading downSecurities exchange commissionInstitutional trading of biocryst pharmaceuticalsBiocryst pharmaceuticalsNeedham companyGet free reportDirector alanExchange commissionCryst pharmaceuticals trading downCryst pharmaceuticalsEight capital

Braskem (NYSE:BAK) Price Target Cut to $10 00 by Analysts at JPMorgan Chase & Co

Braskem (NYSE:BAK – Free Report) had its price target cut by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note published on Friday morning, Benzinga reports. They currently have a neutral rating on the stock. Braskem Trading Down 0.9 % NYSE BAK opened at $7.38 on Friday. The company’s 50-day simple moving […]

United statesRecursos ltdaOptiver holdingBraskem company profileJpmorgan chase coJump financialAlpine global managementFree reportTrading downGet free reportGlobal managementBraskem daily

Braskem (NYSE:BAK) Price Target Lowered to $10 00 at JPMorgan Chase & Co

Braskem (NYSE:BAK – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note issued to investors on Friday, Benzinga reports. They currently have a neutral rating on the stock. Braskem Price Performance Shares of Braskem stock opened at $7.38 on Friday. Braskem has a 1 […]

United statesRecursos ltdaJpmorgan chase coJump financialAlpine global managementOptiver holdingBraskem company profileFree reportGet free reportGlobal managementBraskem daily